Biotechnology is a high-risk, high-reward landscape where innovation determines success. Yet, occasionally, a small player ...

We recently compiled a list of the Why These 15 Healthcare Stocks Are Skyrocketing So Far In 2025. In this article, we are ...

The stock is trading at 1.0150, up 0.6573, gaining 183.7573% on volume of over 422 Million shares, with a day’s high of $1.11 ...

Invivyd's new data highlights Pemgarda's activity against SARS-CoV-2 XEC and over 75% of variants, with consistent neutralization since Omicron BA.1.

In this article, we are going to take a look at where Invivyd Inc (NASDAQ:IVVD) stands against the other healthcare stocks. The healthcare sector is staging a comeback so far in 2025 after two ...

Invivyd (IVVD) announced positive data from its ongoing Phase 1/2 clinical trial of VYD2311, Invivyd’s novel monoclonal antibody candidate ...

Invivyd (NASDAQ:IVVD – Get Free Report)‘s stock had its “buy” rating reissued by equities research analysts at D. Boral ...

Invivyd (IVVD) announced a strategic partnership with professional football coach Jim Harbaugh to raise awareness about the ongoing short and ...

Teaming up to raise awareness of the continuing toll of COVID-19 in America, an ongoing mass disabling event causing an American death approximately every 9 minutes with over 59,0 ...

Enhance your stock picks with dividend metrics like per-share dividends, yield, frequency, payout ratios, and more.